Anticancer Research: 42 (9)

September 2022; Volume 42,Issue 9

Reviews

Open Access
Craniopharyngiomas Invading the Ventricular System: A Systematic Review
PAOLO PALMISCIANO, KURTIS YOUNG, MAYA OGASAWARA, OMID YOUSEFI, CHRISTIAN OGASAWARA, GIANLUCA FERINI, OTHMAN BIN-ALAMER, MAYUR SHARMA, GIUSEPPE E. UMANA, KENNY YU, AARON A. COHEN-GADOL, TAREK Y. EL AHMADIEH and ALI S. HAIDER

Anticancer Research September 2022, 42 (9) 4189-4197; DOI: https://doi.org/10.21873/anticanres.15919
Open Access
Applicability of a Host-mediated In Vivo/In Vitro Model in Screening for the Carcinogenic Potential of Chemicals
KATHRIN SCHLATTERER, ANOOSH ESMAEILI, THOMAS MASSA, SAVVAS APOSTOLIDIS and PRAKASH CHANDRA

Anticancer Research September 2022, 42 (9) 4199-4206; DOI: https://doi.org/10.21873/anticanres.15920
You have access
Screening for Ovarian Cancer in the General Population: State of Art and Perspectives of Clinical Research
ANGIOLO GADDUCCI and STEFANIA COSIO

Anticancer Research September 2022, 42 (9) 4207-4216; DOI: https://doi.org/10.21873/anticanres.15921
Open Access
Comparison of Proportion of Elevated Carcinoembryonic Antigen Levels in Patients With Appendiceal and Colorectal Adenocarcinoma: A Systematic Review and Meta-analysis
ADAM T. CRISTAUDO, SCOTT B. JENNINGS and DAVID L. MORRIS

Anticancer Research September 2022, 42 (9) 4217-4235; DOI: https://doi.org/10.21873/anticanres.15922
You have access
Epithelial to Mesenchymal Transition in Lung Cancer: Potential EMT-Targeting Natural Product-derived Compounds
PITHI CHANVORACHOTE, KORRAKOD PETSRI and SUNISA THONGSOM

Anticancer Research September 2022, 42 (9) 4237-4246; DOI: https://doi.org/10.21873/anticanres.15923
You have access
Evidence of Potential Plant-derived Compounds With Anticancer Effects on Lung Cancer: Clinical and Molecular Pharmacology Approaches
MONRUEDEE SUKPRASANSAP and PITHI CHANVORACHOTE

Anticancer Research September 2022, 42 (9) 4247-4258; DOI: https://doi.org/10.21873/anticanres.15924

Experimental Studies

Open Access
Establishment of Cytotoxic and Non-cytotoxic NK-92 Cell Clones – Evaluation of Their Function as Target Cells
HANS BERGMAN, ELINDA HERMANSON and CHRISTER LINDQVIST

Anticancer Research September 2022, 42 (9) 4259-4264; DOI: https://doi.org/10.21873/anticanres.15925
You have access
Etoposide-induced MicroRNA-205-5p Suppresses Proliferation and Migration by Targeting ERBB4 in MCF-7 Cells
SEUNG WAN SON, SEUNG HYEOK HEO, SANG SU OH, CHAN HEE LEE and JONG KOOK PARK

Anticancer Research September 2022, 42 (9) 4265-4272; DOI: https://doi.org/10.21873/anticanres.15926
You have access
Study of the Acquisition of Sensitivity to Paclitaxel Plus Cetuximab by the Addition of Low-dose Proteasome Inhibitor
MASAKI YODA, KANAME SAKUMA, TOMOYUKI KII and AKIRA TANAKA

Anticancer Research September 2022, 42 (9) 4273-4283; DOI: https://doi.org/10.21873/anticanres.15927
You have access
Effects of Mixed Nuts on Colonic Cell Proliferation and Ptgs2 and Rela Gene Expression
MEE YOUNG HONG, JEFF MOORE, ASHLEY NAKAGAWA and VANESSA NUNGARAY

Anticancer Research September 2022, 42 (9) 4285-4292; DOI: https://doi.org/10.21873/anticanres.15928
You have access
An In Vivo Study of Local Administration of Low-dose Anti-PD-1 Antibody Using an Oral Cancer Cell Line
KANAME SAKUMA, TOMOYUKI KII, HARUKA TAKAHASHI, SUSUMU SUZUKI, KAZUHIRO YOSHIKAWA, TETSUYA OGAWA and AKIRA TANAKA

Anticancer Research September 2022, 42 (9) 4293-4303; DOI: https://doi.org/10.21873/anticanres.15929
Open Access
Verification of A New Filter for Isolation of Circulating Tumor Cells by Only Blood Filtration
KOHEI MORITA, NORIYOSHI SAWABATA, SHIGENOBU TATSUMI, TOMOMI FUJII, TAKASHI NISHIKAWA, TAKESHI KAWAGUCHI, TORU ARAKANE, YOSHIAKI TOMINAGA, HIROKAZU SAKAGUCHI, TARO KOBAYASHI, SHIGETO HONTSU, YOSHIFUMI YAMAMOTO, NOBUHIRO FUJIOKA, NORIKO OUJI-SAGESHIMA, TOSHIHIRO ITO and CHIHO OHBAYASHI

Anticancer Research September 2022, 42 (9) 4305-4310; DOI: https://doi.org/10.21873/anticanres.15930
You have access
The γ-Glutamylcyclotransferase Inhibitor Pro-GA Induces an Antiproliferative Effect Through the Generation of Mitochondrial Reactive Oxygen Species
HIROMI II, KEIKO TANIGUCHI, TAKU YOSHIYA, YUKIE NOHARA, SUSUMU KAGEYAMA, AKIHIRO KAWAUCHI and SUSUMU NAKATA

Anticancer Research September 2022, 42 (9) 4311-4317; DOI: https://doi.org/10.21873/anticanres.15931
You have access
Compound Library Screening for Synergistic Drug Combinations: mTOR Inhibitor and Proteasome Inhibitor Effective Against Osteosarcoma Cells
KUNIHIRO ASANUMA, TOMOKI NAKAMURA, KOICHI NAKAMURA, TOMOHITO HAGI, TAKAYUKI OKAMOTO, KOUJI KITA, YUMI MATSUYAMA, KEISUKE YOSHIDA, YUMIKO ASANUMA and AKIHIRO SUDO

Anticancer Research September 2022, 42 (9) 4319-4328; DOI: https://doi.org/10.21873/anticanres.15932
Open Access
The Contribution of Flap Endonuclease 1 Genotypes to Oral Cancer Risk
SHIH-HAN PAN, WEI-CHING CHIEN, JIE-LONG HE, LIANG-CHUN SHIH, CHE-LUN HSU, TE-CHUN HSIA, YUN-CHI WANG, HAO-YUAN TSAO, CHIA-WEN TSAI, DA-TIAN BAU and WEN-SHIN CHANG

Anticancer Research September 2022, 42 (9) 4329-4335; DOI: https://doi.org/10.21873/anticanres.15933
You have access
Neuroectodermal Rosettes in Immature Teratomas Are Not the Counterpart of Embryonal Tumours With Multilayered Rosettes
NAOMI MAGARIFUCHI, YUICHI YAMADA, YOSHIHIRO OISHI, KIYOKO KATO, KENICHI TAGUCHI and YOSHINAO ODA

Anticancer Research September 2022, 42 (9) 4337-4344; DOI: https://doi.org/10.21873/anticanres.15934
You have access
Aptamer-cocktail Functionalized Nano-microfluidic Chip for Enhancing Isolation and Characterization of Circulating Cancer Cells
MIN LI, DAN LIU, JIAN ZHANG, XIUMING ZHANG and XIAOWEN DOU

Anticancer Research September 2022, 42 (9) 4345-4358; DOI: https://doi.org/10.21873/anticanres.15935
You have access
Implication of IL6-positive Cancer-associated Fibroblasts in Merkel Cell Carcinoma Pathogenesis: A Possible Modulator of Immune Microenvironment
ZHENLONG ZHENG, DAE SAN YOO, SHANSHAN LI, MEILING PEI, SANG GYUN LEE, JI YOUNG KIM, KEE YANG CHUNG and MI RYUNG ROH

Anticancer Research September 2022, 42 (9) 4359-4369; DOI: https://doi.org/10.21873/anticanres.15936
Open Access
Two-Phase Deep Learning Algorithm for Detection and Differentiation of Ewing Sarcoma and Acute Osteomyelitis in Paediatric Radiographs
SARAH CONSALVO, FLORIAN HINTERWIMMER, JAN NEUMANN, MARC STEINBORN, MAYA SALZMANN, FRITZ SEIDL, ULRICH LENZE, CAROLIN KNEBEL, DANIEL RUECKERT and RAINER H.H. BURGKART

Anticancer Research September 2022, 42 (9) 4371-4380; DOI: https://doi.org/10.21873/anticanres.15937
You have access
Genetic and Transcriptional Analysis of 8q24.21 Cluster in Gastric Cancer
BRUNNO SANTOS PEREIRA, FERNANDA WISNIESKI, DANIELLE QUEIROZ CALCAGNO, LEONARDO CAIRES SANTOS, CAROLINA OLIVEIRA GIGEK, ELIZABETH SUCHI CHEN, LUCAS TREVIZANI RASMUSSEN, SPENCER LUIZ MARQUES PAYÃO, RENATA SANCHES ALMEIDA, CAMILA ALBUQUERQUE PINTO, BRUNO TAKAO REAL KARIA, RICARDO ARTIGIANI, SAMIA DEMACHKI, PAULO PIMENTEL ASSUMPÇÃO, LAERCIO GOMES LOURENÇO, CARLOS HARUO ARASAKI, ROMMEL RODRÍGUEZ BURBANO, MARIANA FERREIRA LEAL and MARILIA ARRUDA CARDOSO SMITH

Anticancer Research September 2022, 42 (9) 4381-4394; DOI: https://doi.org/10.21873/anticanres.15938
You have access
The Effect of Trimetazidine on Diathermy-related Thermic Injury of the Rat Liver
SANDOR FERENCZ, ANDRAS PALKOVICS, ANDRAS FINCSUR, ANDRAS VERECZKEI, ILDIKO TAKACS, BALAZS NEMETH and ANDRAS PAPP

Anticancer Research September 2022, 42 (9) 4395-4401; DOI: https://doi.org/10.21873/anticanres.15939
You have access
Magnolol Suppresses ERK/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma
CHI-HUAN LI, MING-CHOU KU, KUN-CHING LEE, PO-FU YUEH, FEI-TING HSU, RONG-FONG LIN, CHUNG-CHI YANG, WEI-CHUN WANG, JIANN-HWA CHEN, LI-CHO HSU and YUAN-HAO LEE

Anticancer Research September 2022, 42 (9) 4403-4410; DOI: https://doi.org/10.21873/anticanres.15940
You have access
Irradiation Methods for Accurate Dose Delivery to Postoperative Keloid Scars With Minimal Normal Tissue Exposure Using TomoTherapy: A Phantom Study
KATSUYA OKUHATA, KENTA KIJIMA, KENJI NAKAMURA, YUYA YANAGI and HAJIME MONZEN

Anticancer Research September 2022, 42 (9) 4411-4415; DOI: https://doi.org/10.21873/anticanres.15941

Clinical Studies

Open Access
Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence
KAZUAKI YASUI, RYOTA KONDOU, HARUO MIYATA, AKIRA IIZUKA, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KEIICHI OHSHIMA, KENICHI URAKAMI, KOJI MURAMATSU, TAKASHI SUGINO, KEN YAMAGUCHI, HIROFUMI OGAWA, TSUYOSHI ONOE, HIDEYUKI HARADA, HIROFUMI ASAKURA, SHIGEYUKI MURAYAMA, TETSUO NISHIMURA, SEIYA GOTO, SHINICHI OKADA, TAKASHI MUKAIGAWA, SATOSHI HAMAUCHI, TOMOYA YOKOTA, YUSUKE ONOZAWA and YASUTO AKIYAMA

Anticancer Research September 2022, 42 (9) 4417-4428; DOI: https://doi.org/10.21873/anticanres.15942
You have access
Survivorship Care Plans Improve the Identification of Post-radiation Hypothyroidism After Head and Neck Cancer Treatment
ZVONIMIR L. MILAS, BRITTANY NEELANDS, SALLY J. TRUFAN, JENNIFER BENBOW, DANIEL CARRIZOSA, DANIEL S. BRICKMAN, CATHERINE H. FRENKEL, ASHLEY L. SUMRALL, SHWETHA M. SUDHAKAR and MATTHEW C. WARD

Anticancer Research September 2022, 42 (9) 4429-4437; DOI: https://doi.org/10.21873/anticanres.15943
Open Access
Analyses of Ocular Adverse Reactions Associated With Anticancer Drugs Based on the Japanese Pharmacovigilance Database
JUNKO TANAKA, TAKENAO KOSEKI, MASASHI KONDO, YASUKI ITO and SHIGEKI YAMADA

Anticancer Research September 2022, 42 (9) 4439-4451; DOI: https://doi.org/10.21873/anticanres.15944
You have access
Assessing Resection Margin Status in Breast-conserving Surgery Specimens: Comparison Among Gross Evaluation, Frozen Section Analysis, and Permanent Section Diagnosis in 725 Patients With Breast Cancer
JEONGEUN DO, JINAH CHU, JAEYOUNG AHN, GO EUN BAE, SANG HWA LEE, HYUN-SOO KIM and SUNG-IM DO

Anticancer Research September 2022, 42 (9) 4453-4460; DOI: https://doi.org/10.21873/anticanres.15945
You have access
Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: A National Study
CHING-TSO CHEN, CHIH-HUNG HSU, ANN-LII CHENG and YU-YUN SHAO

Anticancer Research September 2022, 42 (9) 4461-4470; DOI: https://doi.org/10.21873/anticanres.15946
Open Access
Surgical Strategies to Approaching the Splenic Artery in Robotic Distal Pancreatectomy
KOSEI TAKAGI, KENJIRO KUMANO, YUZO UMEDA, RYUICHI YOSHIDA, TOMOKAZU FUJI, KAZUYA YASUI, TAKAHITO YAGI and TOSHIYOSHI FUJIWARA

Anticancer Research September 2022, 42 (9) 4471-4476; DOI: https://doi.org/10.21873/anticanres.15947
Open Access
Real-world Therapeutic Outcomes of the Pembrolizumab Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Single-center Retrospective Cohort Study in Japan
DAISUKE SANO, MOTOHIKO TOKUHISA, HIDEAKI TAKAHASHI, TAKASHI HATANO, GOSHI NISHIMURA, YASUSHI ICHIKAWA and NOBUHIKO ORIDATE

Anticancer Research September 2022, 42 (9) 4477-4484; DOI: https://doi.org/10.21873/anticanres.15948
You have access
Intraoperative Brachytherapy Combined With Adjuvant Radiotherapy Shows Equal Results in the Treatment of Leiomyosarcoma on the Extremities Compared to Adjuvant Radiotherapy Only – A Multicentric Retrospective Analysis
DIETMAR DAMMERER, ANNELIES VAN BEECK, KATRIN WABRO, KAREN BLOCKHUYS and JOZEF MICHIELSEN

Anticancer Research September 2022, 42 (9) 4485-4492; DOI: https://doi.org/10.21873/anticanres.15949
Open Access
Crypts in Asymmetric Branching in Patients With Ulcerative Colitis in Remission
CARLOS A. RUBIO, MICHAEL VIETH and CORINNA LANG-SCHWARZ

Anticancer Research September 2022, 42 (9) 4493-4497; DOI: https://doi.org/10.21873/anticanres.15950
You have access
Improved Outcome in Pediatric Acute Myeloid Leukemia: Progress With Hematopoietic Cell Transplantation
JOANNA STANKIEWICZ and JAN STYCZYNSKI

Anticancer Research September 2022, 42 (9) 4499-4504; DOI: https://doi.org/10.21873/anticanres.15951
You have access
Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case Series
VERA DALLA VIA, ANNE STELMES, MIKE RECHER, CHRISTIAN ARRANTO, TILL JUNKER, FRANCESCA MATTEAZZI, DOMINIK HEIM, JAKOB R. PASSWEG, MICHAEL MEDINGER and JANA VAN DEN BERG

Anticancer Research September 2022, 42 (9) 4505-4509; DOI: https://doi.org/10.21873/anticanres.15952
Open Access
Evaluation of Sleep Disturbances in Patients With Bladder Cancer Scheduled for Local or Loco-regional Radiochemotherapy
DIRK RADES, SVENJA KOPELKE, STEVEN E. SCHILD, TROELS W. KJAER, SOEREN TVILSTED and TOBIAS BARTSCHT

Anticancer Research September 2022, 42 (9) 4511-4515; DOI: https://doi.org/10.21873/anticanres.15953
You have access
Predicting Long-term Survival After Lung Metastasectomy in Patients With Malignant Germ-cell Tumors
MIRCEA GABRIEL STOLERIU, GEORGIOS STATHOPOULOS, ELVIRA STACHER-PRIEHSE, CHRISTIAN KETSCHER, UWE GRÜTZNER, JAN FERTMANN, CHRISTIAN SCHNEIDER, RUDOLF HATZ, NICOLE STROBL and GERHARD PREISSLER

Anticancer Research September 2022, 42 (9) 4517-4527; DOI: https://doi.org/10.21873/anticanres.15954
Open Access
Sleep Problems Prior to Radio-chemotherapy in Patients With Locally Advanced Cancer of the Esophagus or the Esophagogastric Junction
DIRK RADES, SVENJA KOPELKE, STEVEN E. SCHILD, SOEREN TVILSTED, TROELS W. KJAER and TOBIAS BARTSCHT

Anticancer Research September 2022, 42 (9) 4529-4533; DOI: https://doi.org/10.21873/anticanres.15955
You have access
Molecular Characteristics of Metastatic Lesions Have Superior Prognostic Impact on Endometrial Cancer
KAZUHIRO OKAMOTO, KEIICHIRO NAKAMURA, JUNKO HARAGA and HISASHI MASUYAMA

Anticancer Research September 2022, 42 (9) 4535-4543; DOI: https://doi.org/10.21873/anticanres.15956
You have access
Clinical Impact of Surgical Sarcopenia on Long-term Survival
KEISUKE KOMORI, KAZUKI KANO, TORU AOYAMA, KENTARO HARA, SHINSUKE NAGASAWA, MASATO NAKAZONO, YOTA SHIMODA, YUKIO MAEZAWA, YUTA KUMAZU, TAIICHI KAWABE, MASAKATSU NUMATA, TSUTOMU HAYASHI, TAKANOBU YAMADA, HIROSHI TAMAGAWA, TSUTOMU SATO, HARUHIKO CHO, NORIO YUKAWA, YASUSHI RINO, TAKAKI YOSHIKAWA, TAKASHI OGATA and TAKASHI OSHIMA

Anticancer Research September 2022, 42 (9) 4545-4552; DOI: https://doi.org/10.21873/anticanres.15957
You have access
Prognostic Value of Repeat Hepatectomy for Hepatocellular Carcinoma Patients
ATSUSHI NANASHIMA, YUKINORI TANOUE, MASAHIDE HIYOSHI, NAOYA IMAMURA, KOICHI YANO, TAKEOMI HAMADA, EIJI KITAMURA, KENGO KAI, KOUSEI TAHIRA and TAKESHI NAGAYASU

Anticancer Research September 2022, 42 (9) 4553-4561; DOI: https://doi.org/10.21873/anticanres.15958
You have access
Comparison of Microwave and Radiofrequency Ablation in the Treatment of Pulmonary Metastasis of Colorectal Cancer
CHARIS TAN, OLIVER M. FISHER, LINNA HUANG, NAYEF ALZAHRANI, WINSTON LIAUW, DEREK GLENN and DAVID L. MORRIS

Anticancer Research September 2022, 42 (9) 4563-4571; DOI: https://doi.org/10.21873/anticanres.15959
You have access
Improved Survival of Real-world Japanese Patients With Advanced Renal Cell Carcinoma Treated With Immuno-oncology Combination Therapy
KOSUKE UEDA, SHIGETAKA SUEKANE, HIROFUMI KUROSE, NAOKI ITO, NAOYUKI OGASAWARA, TASUKU HIROSHIGE, KATSUAKI CHIKUI, KAZUHISA EJIMA, KEIICHIRO UEMURA, MAKOTO NAKIRI, KIYOAKI NISHIHARA, MITSUNORI MATSUO and TSUKASA IGAWA

Anticancer Research September 2022, 42 (9) 4573-4580; DOI: https://doi.org/10.21873/anticanres.15960
You have access
Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer
HIRONORI FUJII, SHIORI SADAKA, KANAE AJISAWA, NAOKI OKUMURA, AKITAKA MAKIYAMA, HIROTOSHI IIHARA, ITARU YASUFUKU, KOICHI OHATA, RYO KOBAYASHI, YOSHIHIRO TANAKA, HIDEKI HAYASHI and AKIO SUZUKI

Anticancer Research September 2022, 42 (9) 4581-4588; DOI: https://doi.org/10.21873/anticanres.15961
You have access
Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation
SOU HATTORI, SHINICHIRO OKAUCHI, YUIKA SASATANI, GEN OHARA, KUNIHIKO MIYAZAKI, SHINYA SATO, TAKAHIDE KODAMA, TOSHIHIRO SHIOZAWA, HIROAKI SATOH and NOBUYUKI HIZAWA

Anticancer Research September 2022, 42 (9) 4589-4595; DOI: https://doi.org/10.21873/anticanres.15962
You have access
Detection Ability of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Clinical T Classification of Synchronous Esophageal Cancer in Pharyngeal Cancer
HIDENORI TSUZUKI, HIDENORI SUZUKI, TSUNEO TAMAKI, MICHIHIKO SONE and NOBUHIRO HANAI

Anticancer Research September 2022, 42 (9) 4597-4602; DOI: https://doi.org/10.21873/anticanres.15963
You have access
Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study
SHUNSUKE TATSUKI, TADAHIRO SHOJI, MARINA ABE, HIDETOSHI TOMABECHI, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, TAKESHI AIDA and TSUKASA BABA

Anticancer Research September 2022, 42 (9) 4603-4610; DOI: https://doi.org/10.21873/anticanres.15964
You have access
Impact of GLIM Defined Malnutrition on Long Term Prognosis in Patients With Gastric Cancer After Gastrectomy
RYOTA MATSUI, NORIYUKI INAKI and TOSHIKATSU TSUJI

Anticancer Research September 2022, 42 (9) 4611-4618; DOI: https://doi.org/10.21873/anticanres.15965
You have access
Clinical Outcomes of Limb-sparing Tumor Surgery With Vascular Reconstruction for Bone and Soft-tissue Tumors
YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, YUTA TANIGUCHI, SEI MORINAGA, KAORU TADA, TAKAYUKI NOJIMA and HIROYUKI TSUCHIYA

Anticancer Research September 2022, 42 (9) 4619-4626; DOI: https://doi.org/10.21873/anticanres.15966
You have access
Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors
YURIMI LEE, HYUNSIK BAE and HYUN-SOO KIM

Anticancer Research September 2022, 42 (9) 4627-4639; DOI: https://doi.org/10.21873/anticanres.15967
You have access
First-ever Clinical Experience With Magnetic Resonance-based Lattice Radiotherapy for Treating Bulky Gynecological Tumors
GIANLUCA FERINI, VITO VALENTI, ANNA VIOLA, GIUSEPPE EMMANUELE UMANA, SALVATORE IVAN ILLARI, SILVANA PARISI, ANTONIO PONTORIERO and STEFANO PERGOLIZZI

Anticancer Research September 2022, 42 (9) 4641-4646; DOI: https://doi.org/10.21873/anticanres.15968
You have access
Pheochromocytoma Turned Malignant During Pregnancy in a Patient With Neurofibromatosis Type I - A Case Report and Systematic Review of the Current Literature
CORNELIA ZEITLER, LENA FUDERER, KATJA SCHMITZ, ROHIT ARORA and DIETMAR DAMMERER

Anticancer Research September 2022, 42 (9) 4647-4656; DOI: https://doi.org/10.21873/anticanres.15969

Corrigendum

You have access
Corrigendum
Anticancer Research September 2022, 42 (9) 4657;

Main menu

User menu

Search

Table of Contents

Reviews

Experimental Studies

Clinical Studies

Corrigendum

In this issue

Issue highlights

Jump to